New approach to screen individuals for early Alzheimer's disease
With millions of baby boomers entering late adulthood, the number of patients with Alzheimer's disease (AD) is expected to drastically rise over the next several decades. A team of national researchers, led by Emory University, has developed a rapid screening test to detect mild cognitive impairment (MCI) — often the earliest stage of AD. The findings are published today in the online edition of Journal of Alzheimer's Disease.
The study shows that the combination of a very brief three-minute cognitive screening test, called the Mini-Cog (MC), with a Functional Activities Questionnaire (FAQ) – administered to a family member or friend – could accurately identify individuals with MCI and undiagnosed dementia.
"Since current medications can only delay the onset of Alzheimer's disease but are not able to reverse its devastating effects, a test like this is key to help individuals detect this devastating disease earlier and maintain a good quality of life for as long as possible," says James Lah, MD, associate professor of neurology, Emory University School of Medicine and lead investigator of the study.
The new screening instrument, referred to as the MC-FAQ, allowed the researchers to correctly classify the 204 participating elderly individuals as cognitively normal, demented, or mildly cognitively impaired with a high degree of accuracy (83 percent). Approximately 30 percent of participants had MCI and 32 percent were very mildly demented.
According to Lah, screening for MCI is notoriously difficult and typically requires 40-60 minutes or more of formal neuropsychological testing to achieve 80 percent accuracy or higher. Specific accuracy for classifying people as MCI with the MC-FAQ was 74 percent.
"While this may not seem overly impressive, it is quite remarkable for a 3-minute investment," says Lah. "The MC-FAQ is also extremely inexpensive, easy to administer and score, and requires no special training."
The MC portion of the screening consisted of a simple clock drawing task and three-item recall that typically took the research participant less than five minutes to complete. The FAQ was completed by a reliable informant, generally a spouse, other family member or close friend while the research participant was performing other tasks.
Source: Emory University
Related
- CSIRO scientists announce Alzheimer's disease breakthroughMon, 15 Dec 2008, 9:43:55 EST
- Alzheimer's disease patients show improvement in trial of new drugTue, 29 Jul 2008, 15:22:09 EDT
- Exercise may prevent brain shrinkage in early Alzheimer's diseaseMon, 14 Jul 2008, 16:35:26 EDT
- Study bolsters link to maternal Alzheimer's diseaseWed, 30 Jul 2008, 16:15:50 EDT
- Alzheimer's disease breakthroughMon, 8 Dec 2008, 15:49:29 EST
Share
Other sources
- New Approach To Screen Individuals For Early Alzheimer's Diseasefrom Science DailySat, 22 Nov 2008, 18:21:47 EST
- Scientists seek out Alzheimer's enemiesfrom Science AlertSat, 22 Nov 2008, 8:21:41 EST
- Scientists seek out Alzheimer's enemiesfrom Science AlertThu, 20 Nov 2008, 16:28:29 EST
- New approach to screen individuals for early Alzheimer's diseasefrom PhysorgTue, 18 Nov 2008, 16:07:15 EST
- Scientists seek out Alzheimer's enemiesfrom Science AlertTue, 18 Nov 2008, 9:22:09 EST
- Scientists Seek to Block Progression of Alzheimer`s Disease with Novel Medication that Targets the Sourcefrom PhysorgMon, 17 Nov 2008, 17:49:10 EST
- Alzheimer's disease breakthroughfrom Science CentricMon, 17 Nov 2008, 16:28:49 EST
- Alzheimer's disease breakthroughfrom PhysorgMon, 17 Nov 2008, 13:57:35 EST
- Scientists seek out Alzheimer's enemiesfrom Science AlertMon, 17 Nov 2008, 5:42:08 EST
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Next article
Home-based diet and exercise intervention improves elderly cancer survivors' physical functionLatest breaking news
- Hormone important in recognizing familiar facesTue, 6 Jan 2009, 17:28:35 EST
- Milky Way a swifter spinner, more massive, new measurements showMon, 5 Jan 2009, 13:56:33 EST
- Deep brain stimulation treatment for advanced Parkinson's disease patients provides benefitsTue, 6 Jan 2009, 16:35:41 EST
Popular science news articles
- Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds
- USC dentist links Fosamax-type drugs to jaw necrosis
- Study shows that the societal, economic burden of insomnia is high
- 6 North American sites hold 12,900-year-old nanodiamond-rich soil
- New visualization techniques yield star formation insights
- Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds
- USC dentist links Fosamax-type drugs to jaw necrosis
- Antioxidants offer pain relief in patients with chronic pancreatitis
- New genetic markers for ulcerative colitis identified, researchers report in Nature Genetics
- Peer discussion improves student performance with 'clickers,' says CU-Boulder study
- Brain starvation as we age appears to trigger Alzheimer's
- Facial expressions of emotion are innate, not learned, says new study
- Sugar can be addictive, Princeton scientist says
- Doctors issue warning about the danger of heavy toilet seats to male toddlers
- MRI brain scans accurate in early diagnosis of Alzheimer's disease